Skip to main content
. 2022 Jun 21;6(6):e34995. doi: 10.2196/34995

Table 2.

Change in patient-reported outcomes over time.

Measure (range) Baseline (N=39), mean (SD) 1 month (n=25), mean (SD) 2 months (n=22), mean (SD) 3 months (n=21), mean (SD) 3-month change (95% CI)a P value Linear time trend detected by the latent class model P value
WOMACb pain (0-20 maximal pain) 8.05 (4.19) 6.52 (3.70) 6.36 (4.82) 5.05 (3.89) 2.57 (1.27-3.87) <.001c –0.51 <.001c
WOMAC stiffness (0-8 maximal stiffness) 4.36 (1.74) 3.44 (1.61) 3.00 (1.75) 2.33 (1.65) 1.67 (0.81-2.52) <.001c –0.77 <.001c
WOMAC function (0-68 minimal function) 23.28 (14.21) 17.76 (12.36) 16.32 (13.81) 11.67 (12.70) 8.95 (5.65-12.25) <.001c –0.71 <.001c
BPId (0-10 worse pain) 5.04 (2.17) 4.22 (2.29) 4.16 (1.82) 2.69 (2.18) 2.25 (1.27-3.24) <.001 –0.456 <.001
AUSCANe pain (0-50 worse pain) 6.64 (4.57) 6.00 (4.27) 4.77 (4.08) 3.52 (3.56) 2.33 (0.71-3.96) .007 –0.642 <.001
AUSCAN function (0-90 minimal function) 11.13 (7.63) 8.80 (8.10) 7.45 (7.97) 5.71 (7.27) 4.48 (1.62-7.33) .004 –0.794 <.001
FSIf (0-130 worse fatigue) 53.40 (27.29) 40.04 (26.53) 36.94 (22.02) 29.74 (20.05) 17.53 (6.20-28.86) .004 –0.61 <.001
HFRDISg (0-100 worse hot flash) 28.14 (25.46) 19.27 (22.89) 13.10 (14.25) 12.44 (13.78) 10.15 (2.04-18.26) .02 For 28 patients: –0.176; for 11 patients: –1.235 For 28 patients: .14; for 11 patients: <.001
PSQIh (0-21 lower sleep quality) 18.00 (5.86) 15.04 (6.52) 14.55 (5.70) 11.10 (6.40) 6.14 (3.32-8.96) <.001 –0.626 <.001
CES-Di (0-60 greater depressive symptom severity) 38.33 (5.61) 37.40 (4.53) 36.05 (4.46) 33.95 (4.97) 2.62 (0.26-4.97) .03 –0.353 <.001

aPaired t test.

bWOMAC: Western Ontario and McMaster University Osteoarthritis Index.

cAdjusted for multiple comparison.

dBPI: Brief Pain Inventory.

eAUSCAN: Australian Canadian Osteoarthritis Hand Index.

fFSI: Fatigue Symptom Inventory.

gHFRDIS: Hot Flash Related Daily Interference Scale.

hPSQI: Pittsburgh Sleep Quality Index.

iCES-D: Center for Epidemiological Studies-Depression.